Concizumab (Anti-TFPI)
Product Specifications
CAS Number
1312299-39-0
Synonyms
NN 7415, mAb 2021, Anti-TFPI Recombinant Antibody
Additionnal Information
Concizumab (Anti-TFPI) is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. MW : 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
032054-FITC 200 µL
ARHGEF5, CT (ARHGEF5, TIM, Rho guanine nucleotide exchange factor 5, Ephexin-3, Guanine nucleotide regulatory protein TIM, Oncogene TIM, Transforming immortalized mammary oncogene, p60 TIM) (FITC) discontinued
Sign In for Pricing
View Details 
A00037-FITC 100 µg/Vial
Anti-AAG/MPG Antibody Picoband®, FITC Conjugate
Sign In for Pricing
View Details abx539573 96 Tests
Human POTE ankyrin domain family member I (POTEI) ELISA Kit
Sign In for Pricing
View Details